Jared Baeten, MD, PhD
Department of Medicine
Department of Epidemiology
Professor & Vice Chair, Department of Global Health
Director, University of Washington/Fred Hutch Center for AIDS Research (CFAR)
Sites of Practice: 
Harborview Medical Center

Faculty Information


Dr. Baeten is a professor in the Departments of Global Health, Medicine and Epidemiology at the University of Washington. His research focuses on epidemiologic and biologic risk factors for HIV-1 and other sexually transmitted diseases, and clinical trials of novel interventions for prevention of HIV-1 transmission. He co-chaired the Partners PrEP Study, a phase III, randomized clinical trial among HIV-1 uninfected heterosexual men and women in Kenya and Uganda that demonstrated pre-exposure prophylaxis (PrEP) provided protection against HIV-1 acquisition. Linked projects included a large observational study of PrEP adherence and laboratory analyses of innate and adaptive immune responses related to PrEP use. Other current projects include a) a multinational phase III trial of dapivirine vaginal ring for HIV-1 prevention in women (MTN-020/ASPIRE, through the NIH Microbicides Trials Network, for which he serves as protocol chair), b) implementation studies of combination HIV-1 prevention in South Africa and Uganda, c) epidemiologic studies exploring use of hormonal contraception as a risk factor for HIV-1, and d) demonstration projects to deliver antiretroviral treatment and PrEP for HIV-1 prevention in African HIV-1 serodiscordant couples.

Education & Training: 
PhD, Epidemiology
University of Washington
Seattle, WA
University of Washington
Seattle, WA
Internship and Residency in Primary Care Internal Medicine
Massachusetts General Hospital
Boston, MA
Fellowship in Infectious Diseases
University of Washington
Seattle, WA
Outstanding Mentor Award, University of Washington School of Public Health
Fellow, Infectious Diseases Society of America
University of Washington School of Medicine Alumni Association Early Achievement Award
(206) 520-3808
Mailing Address: 

325 Ninth Ave

2nd Floor West Clinic

Box 359927
Seattle, WA 98104

Research & Clinical Interests
Research Interests: 
  • HIV prevention
  • PrEP
  • Global health
  • Implementation science
  • Reproductive health
Clinical Interests: 
  • HIV primary care
  • PrEP

Mugwanya K, Donnell D, Celum C, Thomas KK, Ndase P, Mugo N, Katabira E, Ngure K, Baeten JM, for the Partners PrEP Study Team. Sexual behavior of heterosexual men and women receiving antiretroviral pre-exposure prophylaxis for HIV prevention. Lancet Infectious Diseases 2013; 13:1021-8.
• PubMed Abstract

Heffron R, Donnell D, Rees H, Celum C, Mugo N, Were E, de Bruyn G, Nakku-Joloba E, Ngure K, Kiarie J, Coombs RW, Baeten JM for the Partners in Prevention HSV/HIV Transmission Study Team. Hormonal contraceptive use and risk of HIV-1 transmission: a prospective cohort analysis. Lancet Infect Dis. 2012; 12(1):19-26.
• PubMed Abstract

Baeten JM, Donnel D, Ndase P, et al for the Partners PrEP Study Team. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012; 367(5):399-410. 
• PubMed Abstract

Baeten JM, Kahle E, Lingappa JR, et al; Partners in Prevention HSV/HIV Transmission Study Team. Genital HIV-1 RNA predicts risk of heterosexual HIV-1 transmission. Sci Transl Med. 2011; 3(77):77ra29.
• PubMed Abstract

Hallett TB, Baeten JM, Heffron R, et al. Optimal uses of antiretrovirals for prevention in HIV-1 serodiscordant heterosexual couples in South Africa: a modelling study. PLoS Med. 2011; 8(11):e1001123. 
• PubMed Abstract

Donnell D, Baeten JM, Kiarie J, et al; Partners in Prevention HSV/HIV Transmission Study Team. Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet. 2010; 375(9731):2092-8. 
• PubMed Abstract